terbutaline has been researched along with xamoterol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Folgering, HT; Lammers, JW; Müller, ME; van Herwaarden, CL | 1 |
| Löfdahl, CG; Svedmyr, N | 1 |
| Haffner, CA; Hughes, B; Kendall, MJ; Maxwell, S | 1 |
| Brodde, OE; Fuchs, B; Gorf, A; Jakubetz, J; Poller, U; Pönicke, K; Radke, J; Schmuck, S | 1 |
4 trial(s) available for terbutaline and xamoterol
| Article | Year |
|---|---|
A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
Topics: Adrenergic beta-Agonists; Adult; Asthma; Atenolol; Blood Pressure; Double-Blind Method; Forced Expiratory Volume; Heart Rate; Hemodynamics; Humans; Lung; Male; Middle Aged; Peak Expiratory Flow Rate; Propanolamines; Random Allocation; Terbutaline; Vital Capacity; Xamoterol | 1986 |
Effects of xamoterol (ICI 118,587) in asthmatic patients.
Topics: Adrenergic beta-Agonists; Adult; Aged; Asthma; Blood Pressure; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Propanolamines; Terbutaline; Tremor; Xamoterol | 1984 |
The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteers.
Topics: Adult; Fatty Acids, Nonesterified; Humans; Lipolysis; Male; Receptors, Adrenergic, beta; Single-Blind Method; Terbutaline; Xamoterol | 1993 |
Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiovascular Physiological Phenomena; Celiprolol; Cross-Over Studies; Diastole; Heart; Heart Rate; Humans; Isoproterenol; Male; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Single-Blind Method; Sympathomimetics; Terbutaline; Time Factors; Xamoterol | 1999 |
5 other study(ies) available for terbutaline and xamoterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |